May 2021 - Page 3 of 6 - BioMedWire (BMW)

TuesdayMay 18, 2021 1:02 pm

Brain Scientific Inc. (BRSF) Featured in Med-Tech News as Technology Provider Revolutionizing Pediatric Brain Diagnostics

BRSF featured in industry publication as a company that transforms EEG testing in children, cutting procedure time from 30 to as little as 5 minutes. The need for brain diagnostics in children is on the rise, but supply and availability of EEG testing to pediatric physicians remains limited. BRSF has stepped in to fill the gap in unmet patients' needs; positioning itself as a leading innovator in this field. Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, was featured in Med-Tech News, a publication covering medical devices medical manufacturing, as a Company revolutionizing the space of pediatric…

TuesdayMay 18, 2021 9:15 am

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Targets Potential Expansion of Rapid COVID-19 Test Kit Distribution with Delivery of 2,000 Units to Israel

XPhyto recently delivered 2,000 of its rapid Covid-ID Lab test kits to an established Israeli distributor for clinical evaluation by the Ministry of Health The delivery, which marks entry into the Middle East, follows the approval of the test kits in Europe In an earlier interview, CEO Hugh Rogers had noted that XPhyto was looking to expand distribution to various markets, including the Middle East In an interview on Proactive on March 22, XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) CEO and Director Hugh Rogers explained the implications of the CE-IVD approval (European certification) the company’s 25-minute COVID-19 RT-PCR…

TuesdayMay 18, 2021 9:00 am

Healthy Extracts Inc. (HYEX) Is Well-Positioned To Capitalize The Growing Demand Of The Nutraceuticals Products Market

Healthy Extracts Inc. through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”) is focused on building a stronghold in the nutraceuticals market BergaMet NA is the only company authorized to manufacture, distribute, and sell Citrus Bergamot SuperFruit(TM) in North America, a supplement enriched with the world’s best quality polyphenols and flavonoids BergaMet North America’s HERHEART(TM) is a natural supplement, scientifically formulated to support woman’s cardiovascular health, as well as managing perimenopausal symptoms Healthy Extracts (OCTQB: HYEX) through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”) is focused on the proprietary research, development, and sale of natural…

MondayMay 17, 2021 2:15 pm

Sleep Disorders Cost the US $95 Billion Annually, Study Finds

We spend a large chunk of our lifetimes asleep — the average person spends around 26 years of their life snoozing, and all this sleep has a major impact on our bodies. Not only does sleep allow us to replenish and recharge after a tiring day, but it is also the time when the body purges itself of toxic waste, repairs cells, and releases useful molecules such as proteins and hormones. If you consistently fail to get enough quality sleep, you greatly increase your risk of getting medical conditions such as diabetes, high blood pressure, heart attack, heart failure or…

MondayMay 17, 2021 9:00 am

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology, will Potentially Reduce High Bladder Cancer Recurrence Rates

Approximately 50% of patients who have bladder cancer will see a recurrence of the condition – often due to poor margin visibility White light has been the standard procedure during cystoscopies, but is only beneficial if tumors protrude from the bladder wall Blue light cystoscopies address this issue, increasing the odds of removing more cancerous cells and reducing the recurrence of the cancer The i/Blue Imaging System(TM) improves surgical technique by combining both white and blue light capabilities on one screen without the necessity of switching between two images Imagin Medical Inc. is currently moving toward commercializing the system, expecting…

FridayMay 14, 2021 2:50 pm

An Infant’s First Stool May Be Used to Predict Their Future Health

A recent study by a group of researchers from the University of British Columbia has found that the composition of meconium can be used to find out whether a baby will develop allergies as they get older. Meconium, which is a child’s first poop, is a thick dark-green substance. The research was reported in the Cell Reports Medicine journal. Dr. Brett Finlay, a professor from the university’s departments of immunology, microbiology, molecular biology and biochemistry, explained that the analysis they conducted showed that compared with babies who didn’t develop allergic sensitization, those who did had considerably less rich meconium after…

FridayMay 14, 2021 12:25 pm

RYAH Group Inc. (CSE: RYAH) Releases “April 2021 Patients Patterns in New York Report” to Provide Data-Driven Insights Amid Latest Legislation Change

RYAH has released April 2021 Patients Patterns in New York Report to bring invaluable data-driven insights within the plant-based health industry amid recent recreational cannabis legislation change in this state. The company leveraged data from 4,387 New York patients within the RYAH Data ecosystem to discover New York-based patients' profiles, including their preferences and medical reasons for use. As an authority in dose-control technology for plant-based medicine, RYAH appears well placed to capitalize on growing market opportunities. RYAH Group (CSE: RYAH) (formerly known as Prime Blockchain Inc.) has announced the release of its "April 2021 Patients Patterns in New York…

FridayMay 14, 2021 12:04 pm

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Maintains Buy Rating in Recent Equity Update

April analyst reports all point to a bright future for Cybin “CYBN is a true multi-molecule company that's not being reflected in its valuation,” reports Stifel “With a relatively small 5% penetration, Cybin could achieve ~$8B in sales in the U.S. and EU5 combined,” notes Roth A series of recent analyst reports bodes well for Cybin (NEO: CYBN) (OTCQB: CLXPF), a leading biotech company focused on progressing psychedelic therapeutics. April reports from Canaccord Genuity equity research company, Stifel GMP (https://ibn.fm/aQ9af) and Roth Capital Partners (https://ibn.fm/YkBNb) all categorize Cybin as a buy, with Stifel increasing its price target from $5 to…

ThursdayMay 13, 2021 1:22 pm

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Working Towards a Better Future for Bladder Cancer Patients

Bladder cancer is still the sixth most prevalent cancer in the U.S. in 2021 The total number of new bladder cancer cases is expected to reach 83,730, with deaths totaling 17,200 this year Imagin Medical Inc. is hoping to offer a better standard of care for bladder cancer patients with its i/Blue Imaging System(TM) that improves visualization for resection, potentially lowering recurrence rates According to American Cancer Society statistics, the number of cases of all types of cancer this year will total almost 1.9 million, with 608,570 deaths, or approximately 5,200 new cases and 1,670 deaths per day (https://ibn.fm/eDdCz). Of…

ThursdayMay 13, 2021 12:05 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Builds Alliances Ahead of Psychedelic Drug Trial for Eating Disorders

Orphan-stage pharmaceutical innovator Tryp Therapeutics is dedicated to developing novel therapies for medical conditions with unmet needs Tryp’s embrace of psychedelic drug potential is demonstrated in its advancing clinical trials seeking an answer to eating disorders such as binge eating and hyperphagia The company is also developing a clinical trial to address the needs of fibromyalgia patients who often rely on opioids to relieve their symptoms Tryp has announced two new collaborations for oversight of the drug trials this month; consultants with Fluence and Clinlogix will help to ensure the quality of the tests Bioscience pharmaceutical company Tryp Therapeutics (CSE:…

News and publishing service for medical and biotechnology related companies

Contact us: 415.949.5050

Month: May 2021

Brain Scientific Inc. (BRSF) Featured in Med-Tech News as Technology Provider Revolutionizing Pediatric Brain Diagnostics

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Targets Potential Expansion of Rapid COVID-19 Test Kit Distribution with Delivery of 2,000 Units to Israel

Healthy Extracts Inc. (HYEX) Is Well-Positioned To Capitalize The Growing Demand Of The Nutraceuticals Products Market

Sleep Disorders Cost the US $95 Billion Annually, Study Finds

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Technology, will Potentially Reduce High Bladder Cancer Recurrence Rates

An Infant’s First Stool May Be Used to Predict Their Future Health

RYAH Group Inc. (CSE: RYAH) Releases “April 2021 Patients Patterns in New York Report” to Provide Data-Driven Insights Amid Latest Legislation Change

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Maintains Buy Rating in Recent Equity Update

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Working Towards a Better Future for Bladder Cancer Patients

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Builds Alliances Ahead of Psychedelic Drug Trial for Eating Disorders

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search